Home
Eureka Therapeutics

Eureka Therapeutics Market Share Analysis for June 2026

The first patient with GPC3-positive advanced hepatocellular carcinoma (HCC), the predominant type of liver cancer, was treated with ECT204 T cell therapy.

Health > Biotechnology and Pharmaceuticals

Domaineurekatherapeutics.com

Year Founded2006

Employees51 - 200

Annual Revenue$25M - $50M

Eureka Therapeutics

Eureka Therapeutics (including company regionals)

eurekatherapeutics.com

See more website traffic and engagement information

Eureka Therapeutics Revenue up to June 2026 is 25M - 50M

revenue generated by Eureka Therapeutics top domains

Eureka Therapeutics top domains revenue over 3 years

Revenue for Eureka Therapeutics top domains

eurekatherapeutics.com25M - 50M

See more with Sales Intelligence

Total visits to Eureka Therapeutics's top domains

Understand Eureka Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

eurekatherapeutics.com2.5K

See more with Sales Intelligence

Avg. visit duration in Eureka Therapeutics's top domains

Analyze Eureka Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

eurekatherapeutics.com00:00:46

See more with Sales Intelligence

Avg. pageviews on Eureka Therapeutics's top domains

See how Eureka Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

eurekatherapeutics.com2.23

See more with Sales Intelligence

Eureka Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

astellasgenetherapies.comCompany NameAstellas Gene TherapiesEmployees201 - 500HQUnited States, California, San FranciscoAnnual revenue$75M - $100MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Eureka Therapeutics

These are the website technologies, by industry, used by Eureka Therapeutics top domains

Social (9)

Google+ Platform

Widget (6)

Twemoji

Conversion & Analytics (4)

Google Analytics

Audio Video Media (3)

YouTube

More Technologies

8

See all

News & Signals from Eureka Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHepatoblastoma website partnered with Eureka Therapeutics, Inc. on Feb 23rd '26.In honor of Rare Disease Day, the Hepatoblastoma Resource Network is partnering with Eureka Therapeutics to host a special webinar featuring a parent and patient advocate perspective on Monday, February 23, 2026 from 1:00-1:45 ET.

NewsEureka Therapeutics, Inc. hired Reginald Seeto as Board of Directors on Aug 12th '25.Emeryville, Calif., August 12th, 2025 - Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Dr. Reginald Seeto and William S. Solari III to its Board of Directors.